Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
national blog main
new york blog main
6
×
life sciences
san francisco blog main
startups
deals
national top stories
boston blog main
boston top stories
new york top stories
san diego blog main
san francisco top stories
vc
boston
diabetes
fda
lifesci venture partners
medical device
raleigh-durham blog main
roboticsai
san diego top stories
software
acetylon pharmaceuticals
alex gorsky
ambys medicines
aphelion capital
arboretum ventures
arrowmark partners
ashley mcevoy
auris health
aurora health care
azacitidine
baird capital
beta bionics
beta-thalassemia
bigfoot biomedical
biolinq
boston university
cancer
What
startup
6
×
based
million
new
biotech
closed
deal
developing
diabetes
medical
medicines
research
step
acquiring
adds
advance
aiming
aims
ambys
ann
approach
arbor
auris
beta
big
billion
biolinq
bionics
biosensor
blood
builds
buy
called
cash
company
company’s
control
deadly
debuted
debuts
Language
unset
Current search:
biotech
×
startup
×
" new york blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
